[{"notes_id":"1_2207","category":"11","subcategory":"4","title":"Breast cancer: management","body":"The management of breast cancer depends on the staging, tumour type and patient background. It may involve any of the following:<br \/><ul><li>surgery<\/li><li>radiotherapy<\/li><li>hormone therapy<\/li><li>biological therapy<\/li><li>chemotherapy<\/li><\/ul><br \/><h5 class='notes-heading'>Surgery<\/h5><br \/>The vast majority of patients who have breast cancer diagnosed will be offered surgery. An exception may be a very frail, elderly lady with metastatic disease who may be better managed with hormonal therapy.<br \/><br \/>Prior to surgery, the presence\/absence of axillary lymphadenopathy determines management:<br \/><ul><li><span class=\"concept\" data-cid=\"10185\">women with no palpable axillary lymphadenopathy at presentation should have a pre-operative axillary ultrasound<\/span> before their primary surgery<ul><li><span class=\"concept\" data-cid=\"10186\">if negative then they should have a sentinel node biopsy to assess the nodal burden<\/span><\/li><\/ul><\/li><li><span class=\"concept\" data-cid=\"10189\">in patients with breast cancer who present with clinically palpable lymphadenopathy, axillary node clearance is indicated at primary surgery<\/span><ul><li><span class=\"concept\" data-cid=\"10191\">this may lead to arm lymphedema and functional arm impairment<\/span><\/li><\/ul><\/li><\/ul><br \/>Depending on the characteristics of the tumour women either have a wide-local excision or a mastectomy. Around two-thirds of tumours can be removed with a wide-local excision. The table below lists some of the factors determining which operation is offered:<br \/><br \/><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Mastectomy<\/b><\/th><th><b>Wide Local Excision<\/b><\/th><\/tr><\/thead><tbody><tr><td>Multifocal tumour<\/td><td>Solitary lesion<\/td><\/tr><tr><td>Central tumour<\/td><td>Peripheral tumour<\/td><\/tr><tr><td>Large lesion in small breast<\/td><td>Small lesion in large breast<\/td><\/tr><tr><td>DCIS > 4cm<\/td><td>DCIS < 4cm<\/td><\/tr><\/tbody><\/table><\/div><br \/>Women should be offered breast reconstruction to achieve a cosmetically suitable result regardless of the type of operation they have. For women who've had a mastectomy this may be done at the initial operation or at a later date.<br \/><br \/><h5 class='notes-heading'>Radiotherapy<\/h5><br \/><span class=\"concept\" data-cid=\"9151\">Whole breast radiotherapy is recommended after a woman has had a wide-local excision as this may reduce the risk of recurrence by around two-thirds<\/span>. For women who've had a mastectomy radiotherapy is offered for T3-T4 tumours and for those with four or more positive axillary nodes<br \/><br \/><h5 class='notes-heading'>Hormonal therapy<\/h5><br \/>Adjuvant hormonal therapy is offered if tumours are positive for hormone receptors. For many years this was done using tamoxifen for 5 years after diagnosis. <span class=\"concept\" data-cid=\"3967\">Tamoxifen is still used in pre- and peri-menopausal women<\/span>. In <span class=\"concept\" data-cid=\"1261\">post-menopausal women, aromatase inhibitors such as anastrozole<\/span> are used for this purpose*. This is important as aromatisation accounts for the majority of oestrogen production in post-menopausal women and therefore anastrozole is used for ER +ve breast cancer in this group. <br \/><br \/>Important side effects of tamoxifen include an increased risk of endometrial cancer, venous thromboembolism and menopausal symptoms.<br \/><br \/><h5 class='notes-heading'>Biological therapy<\/h5><br \/>The most common type of biological therapy used for breast cancer is <span class=\"concept\" data-cid=\"3966\">trastuzumab (Herceptin)<\/span>. It is only useful in the 20-25% of tumours that are <span class=\"concept\" data-cid=\"3966\">HER2 positive<\/span>.<br \/><br \/>Trastuzumab cannot be used in patients with a history of heart disorders.<br \/><br \/><h5 class='notes-heading'>Chemotherapy<\/h5><br \/>Cytotoxic therapy may be used either prior to surgery ('neoadjuvanant' chemotherapy) to <span class=\"concept\" data-cid=\"10193\">downstage a primary lesion<\/span> or after surgery depending on the stage of the tumour, for example, if there is <span class=\"concept\" data-cid=\"3968\">axillary node disease - FEC-D is used in this situation<\/span>.","notes_hash":"a1625b661574094c033c3b6808a7a993","knowledge_graph_node_id_link":1030,"links":"<table style='width:100%'><tr><td>NICE<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_433\" data-linkid=\"433\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_433\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">17<\/span><button type=\"button\" style=\"\" id=\"link_dislike_433\" data-linkid=\"433\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_433\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">9<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/www.nice.org.uk\/guidance\/ng101\/chapter\/Recommendations\">Early and locally advanced breast cancer: Diagnosis and treatment<\/a><\/td><\/tr><\/table>","media":"<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/KgrXNlk89vs\" data-description=\"Pharmacology - CANCER DRUGS - HORMONAL THERAPY\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"1066\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/KgrXNlk89vs\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/KgrXNlk89vs\" data-description=\"Pharmacology - CANCER DRUGS - HORMONAL THERAPY\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"1066\">Pharmacology - CANCER DRUGS - HORMONAL THERAPY<\/a><\/td><\/tr><tr><td><span ><small>Speed Pharmacology - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1859\" data-mediaid=\"1859\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_1859\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2<\/span><button type=\"button\" style=\"\" id=\"media_dislike_1859\" data-mediaid=\"1859\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_1859\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0<\/span><\/td><\/tr><tr><td>&nbsp;<\/td><\/tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/jPtCkcILCGU\" data-description=\"Breast cancer\" data-upvotes=\"4\" data-downvotes=\"2\" data-media=\"701\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/jPtCkcILCGU\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/jPtCkcILCGU\" data-description=\"Breast cancer\" data-upvotes=\"4\" data-downvotes=\"2\" data-media=\"701\">Breast cancer<\/a><\/td><\/tr><tr><td><span ><small>Osmosis - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1226\" data-mediaid=\"1226\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_1226\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">4<\/span><button type=\"button\" style=\"\" id=\"media_dislike_1226\" data-mediaid=\"1226\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_1226\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2<\/span><\/td><\/tr><\/table>","concepts_for_notes":{"1261":{"concept_text":"Adjuvant hormonal therapy for ER +ve breast cancer: anastrozole in post-menopausal women ","concept_percentile":"62"},"9151":{"concept_text":"Whole breast radiotherapy is recommended after a woman has had a wide-local excision as this may reduce the risk of recurrence by around two-thirds","concept_percentile":"68"}},"category_name":"Reproductive","subcategory_name":"Breast surgery","comment_count":9},"",[]]